Inozyme Pharma is a biotechnology company developing new medicines to treat rare, debilitating, and life-threatening calcification disorders for which there are no adequate treatment options. We are focused on devastating and debilitating rare diseases that largely impact infants, children, and young adults. In certain rare, life-threatening, and devastating genetic disorders, PPi levels are below the normal levels. These low ...
Inozyme Pharma is a biotechnology company developing new medicines to treat rare, debilitating, and life-threatening calcification disorders for which there are no adequate treatment options. We are focused on devastating and debilitating rare diseases that largely impact infants, children, and young adults. In certain rare, life-threatening, and devastating genetic disorders, PPi levels are below the normal levels. These low levels can lead to over-mineralization of soft tissues and/or under-mineralization of bone, which cause damage and disease to bones, arteries, and organs.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.